Dr Sally Ann Forsyth CEO Stevenage Bioscience Catalyst Awarded OBE for Services to Business and Science
Dr Sally Ann Forsyth, CEO of Stevenage Bioscience Catalyst (SBC), thanks her colleagues and collaborators after being honoured in the 2021 New Year Honours list. Sally Ann has been awarded an Officer of the Order of the British Empire (OBE) for services to business...
Stevenage Bioscience Catalyst opens the lab hotel with it’s first residents
Stevenage Bioscience Catalyst (SBC), a leading location for development and commercialisation of cutting-edge therapeutics, is pleased to announce the opening of the Lab Hotel, a lab and office facility for early-stage start-ups in the field of advanced therapeutics...
New report shows 10% of UK’s top female BioBusiness talent is based at Stevenage Bioscience Catalyst
A report released today by BioBeat showcasing the 30 top female leaders in the UK bioscience sector has named three people from organisations based at Stevenage Bioscience Catalyst (SBC), totalling 10% of the list. The three mentioned leaders based at SBC are Shree...
Stevenage Bioscience Catalyst opens Spark Building to support Cell and Gene scale-up
Stevenage Bioscience Catalyst’s new Spark Building opened its doors to accommodate the rapid growth of scale-up businesses within Hertfordshire’s world-class cell and gene cluster. The Spark Building was built to accommodate the companies scaling up to create a new...Stevenage named high potential opportunity zone for cell and gene therapy
The Department for International Trade (DIT) has classified Stevenage, Hertfordshire, as a High Potential Opportunity (HPO) zone in recognition of its thriving cell and gene therapy cluster of national and international significance. The successful HPO nomination was...
